Columbia Financial management will participate in investor meetings hosted by Piper Sandler on November 17 and 18, 2026. The company will discuss a presentation that will be made available on its Investor Relations website.
Henry Schein announced a voluntary change to its non-GAAP financial reporting to exclude acquisition-related remeasurement gains starting in Q4 2026. Consequently, the company updated its FY2026 non-GAAP diluted EPS guidance to $5.42-$5.48 from $5.50-$5.56 to reflect this accounting adjustment, with no change to its underlying business outlook.
Nektar Therapeutics reaffirmed its financial guidance, stating that its current cash and marketable securities balance of $952.9 million is expected to fund operations into the third quarter of 2028. This runway is intended to support the company through the initial Phase 3 data readouts for its ZENITH AD trials in atopic dermatitis, expected in the summer of 2028.
Elevance Health officers are meeting with investors and analysts to reaffirm the company's full-year 2026 financial guidance. The company continues to expect adjusted shareholders’ earnings of at least $29.00 per diluted share and a benefit expense ratio of 90.2% plus or minus 50 basis points.
Chairman and CEO Brad Jacobs hosted a conference call to discuss QXO's preliminary third-quarter results and business outlook. During the call, Jacobs reaffirmed his commitment to QXO while also discussing a separate $1 billion investment venture into CKX Lands.
Veeva Systems reaffirmed its financial guidance for the third quarter of fiscal year 2027 during its 2026 Investor Day. CFO Brian Van Wagener stated the company expects to meet or exceed the previously issued targets, including total revenue between $932 million and $935 million. The filing serves as a Regulation FD disclosure to confirm that the company's outlook remains on track.
Oceaneering International announced that an investor handout will be used during upcoming institutional investor meetings. The handout will be available on the company's website starting November 5, 2026, after market close.
NBT Bancorp Inc. announced that its executive management team intends to use a new presentation during upcoming meetings with investors and analysts. The presentation slides have been made available on the company's investor relations website.
Artificial Intelligence Technology Solutions (AITX) announced updated financial projections, targeting monthly operating cash breakeven by January 2027 and all-in cash breakeven by Q2 2027. The company is implementing an expanded cost-savings program expected to exceed $350,000 per month by February 2027 while focusing development on its SARA, RAIA, and ROAMEO platforms.
EquipmentShare.com Inc raised its full-year 2026 financial guidance, increasing its total revenue outlook to a range of $5.81B to $6.05B. The company cited strong customer demand, high fleet utilization, and increasing productivity across its expanding rental network as primary drivers for the improved outlook.
Evolution Metals & Technologies Corp. reaffirmed its fiscal 2027 revenue guidance of $400 million to $460 million and provided an update on its magnet grade portfolio. The company also announced plans to begin acquiring equipment for samarium cobalt (SmCo) magnet production by mid-2027 to address U.S. military requirements.
Advasa Holdings announced its five-year medium-term operating goals through March 2031, targeting a significant scale-up in financial performance. The company aims to grow consolidated revenue from $18.99 million in fiscal 2027 to $632.91 million by fiscal 2031, with corresponding operating income targets rising to $189.87 million.
Game Your Game, Inc. announced that it has posted an updated investor presentation to its website. The presentation is intended for use in upcoming meetings and conferences with investors and analysts.
Drilling Tools International Corporation has engaged a Norwegian investment bank to arrange a series of fixed income investor meetings in the Nordic market starting October 14, 2026. These meetings are in preparation for a contemplated U.S. dollar denominated senior secured bond issue intended to finance the acquisition of Saltire Energy Limited and refinance existing debt.
Evolution Metals & Technologies Corp. raised its fiscal 2026 revenue guidance to $10–$11 million, a 62% increase at the midpoint from previous estimates, while reaffirming its fiscal 2027 revenue outlook of $400–$460 million. The upward revision is driven by expanded rare earth feedstock positions and the scheduled delivery of thirteen additional ULVAC production machines to its Pohang facility in October 2026.
Humana reaffirmed its FY 2026 adjusted EPS guidance of at least $9.00 and provided an update on its 2027 Medicare Advantage Star Ratings from CMS. The company achieved its goal of Top Quartile results, which it expects will provide a one-time financial benefit in 2028 to be used for investments and shareholder returns.
Velo3D CEO Arun Jeldi reaffirmed the company's existing revenue guidance and financial outlook in a social media post. The communication stated that recent organizational changes have had no impact on customer relationships and that the company is on track for its year-end performance targets.
MicroVision held a virtual business update event to reaffirm its 2026 revenue guidance of $10 million to $15 million and project a doubling of revenue in 2027. Management outlined a 'Lidar 2.0' strategy focused on commercial execution across industrial, defense, and AI data center markets while planning a significant reduction in cash burn for 2027.
HubSpot reaffirmed its Q3 2026 and full-year 2026 financial guidance while announcing a restructuring plan to eliminate approximately 7% of its workforce (660 employees). The company expects to incur restructuring charges between $65 million and $75 million as it reorganizes to focus on AI-driven customer outcomes and a flatter management structure.
Camping World Holdings lowered its full-year 2026 Adjusted EBITDA guidance to below the previous range of $230 million to $270 million due to softening RV demand and margin pressure. In response, the company implemented $50 million in incremental annualized cost savings, including headcount reductions and the closure of four dealerships. The company also announced it is exploring a refinancing of its existing term loan facility to increase financial flexibility.
Cardinal Health entered into a binding letter of intent to extend its pharmaceutical distribution agreements with CVS Health through June 2032. In connection with the extension, the company reaffirmed its fiscal year 2027 non-GAAP EPS guidance of $12.40 to $12.60 and its long-term growth targets.
NCL Corporation's parent company, Norwegian Cruise Line Holdings Ltd., announced that it expects third-quarter 2026 results to exceed previous guidance due to strong revenue performance. The company also reaffirmed its full-year 2026 guidance and provided a 2027 net interest expense forecast of $860-$880 million.
Norwegian Cruise Line Holdings Ltd. announced that it expects its third-quarter 2026 results to exceed previous guidance due to strong revenue performance. The company also reaffirmed its full-year 2026 guidance and provided a 2027 net interest expense forecast of $860-$880 million following recent subsidiary transactions.
Workday announced a strategic reorganization involving a 2.5% workforce reduction, primarily in its Product and Technology teams, and select office space reductions. The company expects to incur $65 million to $80 million in total charges while reiterating its fiscal 2027 third quarter and full-year financial guidance, adjusting only for the GAAP operating margin impact of these restructuring costs.
Tessera Defense and Homeland Security Inc. issued a press release outlining its long-term financial targets, including a 2027 revenue target of $14-$16 million. The company further projected revenue growth to $21 million in 2028 and $30 million in 2029, representing a 40% CAGR from the 2027 midpoint. The strategy focuses on scaling its integrated physical security platform across critical infrastructure and energy sectors.
Iovance Biotherapeutics raised its full-year 2026 total revenue guidance to a range of $410 million to $420 million, up from the previous range of $350 million to $370 million. The increase is driven by strong U.S. demand for its cancer therapies Amtagvi and Proleukin, representing approximately 60% annual growth.
Gen Digital CEO Vincent Pilette issued a public update via social media to address acquisition rumors and reaffirm the company's financial outlook. The company confirmed it is tracking to the higher end of its guidance for the quarter ending October 2, 2026, and maintained its fiscal 2027 growth targets.
BGC Group reaffirmed its previously stated financial outlook for the third quarter ending September 30, 2026. The company maintained its existing ranges for both revenue and pre-tax Adjusted Earnings as originally issued on July 30, 2026.
Gray Media raised its Q3 2026 financial guidance, specifically increasing its political advertising revenue expectations to $188-$195 million and lifting the low end of its total revenue range to $950-$965 million. The update was provided in connection with upcoming lender meetings to refinance its credit facility and presentations to institutional investors. The company also lowered its expected corporate and administrative expenses for the quarter.
Labcorp is reaffirming its 2026-2029 long-term financial outlook following the release of preliminary Medicare payment rates by CMS. The company expressed concern that the proposed rates would impose steep annual cuts and is continuing to support the bipartisan RESULTS Act to ensure a sustainable laboratory system.